bioRxiv Science⌕ Search

Biology subjects

Jones, O. A.

Publications and source records attributed to Jones, O. A..

2 recordsLinked to original sources

Voxel-wise tracer kinetic model selection for DCE-MRI measurements of blood-brain barrier leakage

PurposeTo apply voxel-wise tracer kinetic model selection, characterise the spatial distribution of best-fitting models across the brain, and evaluate whether model selection improves sensitivity for differentiating normal-appearing tissue from pathological tissue compared to the Patlak model. MethodsExtended Tofts, Patlak, and intravascular models were fit to DCE-MRI data from stroke survivors and controls, as well as simulated data. The best-fitting model was chosen for each voxel using the Akaike Information Criterion, and model selection Ktrans (estimates from the best-fitting model for each voxel) compared to Patlak model Ktrans. ResultsIn simulated data, the Extended Tofts model was best-fitting at Ktrans>10-3 min-1, where the Patlak model systematically underestimated Ktrans. Patlak was optimal at Ktrans between 10-4-10-3 min-1, where Extended Tofts estimates had greater variability. The intravascular model was selected for Ktrans[~]10-4 min-1. The Patlak model was chosen in most control voxels. In chronic stroke, the Extended Tofts model was preferred in most cortical and white matter hyperintensity voxels, while the Patlak model was selected in most deep grey matter and normal-appearing white matter voxels. Model selection Ktrans estimates were significantly greater than Patlak estimates in the cortex and white matter hyperintensities, with greater inter-patient variability, likely reflecting biological variability in blood-brain barrier leakage resulting from stroke. ConclusionVoxel-wise model selection may provide more accurate estimates of a wider range of Ktrans values than any single model, revealing greater differences between normal and pathological tissue and offering a more sensitive and physiologically appropriate framework for DCE-MRI analysis of blood-brain barrier dysfunction.

neuroscience↗

Blood-brain barrier dysfunction predicts cognitive trajectory after ischemic stroke

Ischemic stroke doubles the risk of dementia.1-4 Stroke severity and location affect cognition early,5,6 but late dementia risk is not related to infarct characteristics, nor is it reduced by preventing additional strokes,3,6,7 and its mechanism is unknown. We identified a plasma proteomic signature of chronic stroke that was consistent with blood-brain barrier (BBB) dysfunction, including a 58% decrease in plasma levels of platelet-derived growth factor B and downregulation of its pathway compared to healthy controls. During 2 years of follow-up, the stroke-specific proteome was accentuated in stroke survivors who subsequently declined in the processing speed/executive function cognitive domain. To test BBB function, we performed dynamic contrast-enhanced MRI 6-9 months after stroke in an additional cohort and found 1.7-fold higher whole brain BBB leakage compared to controls. Finally, we compared autopsy tissue from people with infarcts and dementia at death to those with infarcts and no dementia. Those who died with dementia had dramatic loss of vascular mural cell coverage compared to those without dementia (median 0.7% vs. 27%). Thus, our proteomic, functional, and structural data implicate chronic BBB dysfunction in cognitive decline late after stroke, revealing potential proteomic and imaging biomarkers and, importantly, a novel target for intervention.

neuroscience↗